Spellman, Stephen R.

Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation

Lindsley, R. C., Saber, W., Mar, B. G., Redd, R., Wang, T., Haagenson, M. D., Grauman, P. V., Hu, Z.-H., Spellman, S. R., Lee, S. J., et al. (2017) · New England Journal of Medicine

Acute Myeloid Leukemia ResearchHematopoietic Stem Cell Transplantation

Cited by 776

High HLA-DP Expression and Graft-versus-Host Disease

Petersdorf, E. W., Malkki, M., O’hUigin, C., Carrington, M., Gooley, T., Haagenson, M. D., Horowitz, M. M., Spellman, S. R., Wang, T., & Stevenson, P. (2015) · New England Journal of Medicine

Hematopoietic Stem Cell TransplantationGenetic Associations and Epidemiology

Cited by 278

New HLA haplotype frequency reference standards: high-resolution and large sample typing of HLA DR-DQ haplotypes in a sample of European Americans

Klitz, W., Maiers, M., Spellman, S., Baxter‐Lowe, L. A., Schmeckpeper, B., Williams, T. M., & Fernandez‐Viña, M. (2003) · Tissue Antigens

Genetic Associations and EpidemiologyRenal Transplantation Outcomes and Treatments

Cited by 179

Association Between Donor Leukocyte Telomere Length and Survival After Unrelated Allogeneic Hematopoietic Cell Transplantation for Severe Aplastic Anemia

Gadalla, S. M., Wang, T., Haagenson, M., Spellman, S. R., Lee, S. J., Williams, K. M., Wong, J. Y., De Vivo, I., & Savage, S. A. (2015) · JAMA

Hematopoietic Stem Cell TransplantationTelomeres, Telomerase, and Senescence

Cited by 95